Areta Kupchyk's most recent trade in Anebulo Pharmaceuticals Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anebulo Pharmaceuticals Inc | Areta Kupchyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Areta Kupchyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 2,647 | 2,647 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Areta Kupchyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 41,667 | 41,667 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Areta Kupchyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 1,324 | 1,324 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Areta Kupchyk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2022 | 30,425 | 30,425 | - | - | Stock Option (right to buy) |